Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients with Reduced Ejection Fraction and Iron Deficiency
Reviews in Cardiovascular Medicine · 17.04.2025 · 26 (4)
DOI: 10.31083/rcm28216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 17.04.2025. Verfasst von Hsiao-Ping Sung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, Cheng Hsin General Hospital, 112 Taipei. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cheng Hsin General Hospital.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
The concurrent presence of iron deficiency (ID) and heart failure (HF) can worsen prognosis and reduce the quality of life for affected individuals. This study aimed to explore the effects of incorporating iron sucrose into standard HF treatments for patients with acute decompensated HF and ID.
Methods
We prospectively enrolled 65 hospitalized HF patients, all with a left ventricular ejection fraction of ≤40% and ID, defined as ferritin levels below 100 ng/mL or ferritin levels between 100 and 299 ng/mL with transferrin saturation below 20%. Patients were randomized into two groups: the iron sucrose group, who received intravenous iron sucrose in addition to the standard HF treatment; a control group who received standard HF treatment alone serum ferritin, iron, transferrin saturation, and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores were measured at baseline and a 4-week follow-up.
Results
Baseline characteristics, iron profiles, and KCCQ scores were comparable between the two groups. At 4 weeks, patients in the iron sucrose group possessed significantly higher serum ferritin levels than those in the control group (ferritin 485.3 ± 269.7 ng/mL vs. 225.5 ± 162.5 ng/mL, p < 0.001; Δferritin 382.2 ± 243.5 ng/mL vs. 97.4 ± 143.0 ng/mL, p < 0.001, respectively). Only 9.1% of patients in the iron sucrose group remained within the ID criteria, compared to 36.7% in the control group (p = 0.012). The ΔKCCQ score was 10.6 points higher (27.8 ± 19.5 vs. 17.1 ± 17.8 points, p = 0.031) in the iron sucrose group than in the control group.
Conclusions
Post-discharge intravenous iron sucrose may improve iron levels and quality of life in HF patients with ID. Clinical trial registration: NCT06703411, https://clinicaltrials.gov/expert-search?term=NCT06703411.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Center, Cheng Hsin General Hospital, 112 Taipei.
- Community Medicine Research Center, Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, 112 Taipei.
- School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, 112 Taipei.
- Department of Physical Medicine and Rehabilitation, Cheng Hsin General Hospital, 112 Taipei.
- Department of Physiology and Biophysics, National Defense Medical Center, 114 Taipei.
- Division of Cardiology, Departments of Internal Medicine, MacKay Memorial Hospital, 104 Taipei.
ORCID-Profile: Hsiao-Ping Sung, Wei-Hsian Yin, Szu-Fu Chen, Chung-Lieh Hung, Kuan-Chia Lin, Hung-Yu Chang
Förderung
- Cheng Hsin General Hospital
Zitieren
APA
Sung, H. P., Yin, W. H., Chen, S. F., Hung, C. L., Lin, K. C., & Chang, H. Y. (2025). Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients with Reduced Ejection Fraction and Iron Deficiency. Reviews in Cardiovascular Medicine, 26(4). https://doi.org/10.31083/rcm28216
Vancouver
Sung HP, Yin WH, Chen SF, Hung CL, Lin KC, Chang HY. Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients with Reduced Ejection Fraction and Iron Deficiency. Reviews in Cardiovascular Medicine. 2025;26(4). doi:10.31083/rcm28216
BibTeX
@article{Sung2025,
author = {Sung, Hsiao-Ping and Yin, Wei-Hsian and Chen, Szu-Fu and Hung, Chung-Lieh and Lin, Kuan-Chia and Chang, Hung-Yu},
title = {Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients with Reduced Ejection Fraction and Iron Deficiency},
journal = {Reviews in Cardiovascular Medicine},
year = {2025},
volume = {26},
number = {4},
doi = {10.31083/rcm28216}
}
EUVIMED